These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 17940885)

  • 1. The place of choline acetyltransferase activity measurement in the "cholinergic hypothesis" of neurodegenerative diseases.
    Contestabile A; Ciani E; Contestabile A
    Neurochem Res; 2008 Feb; 33(2):318-27. PubMed ID: 17940885
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Choline acetyltransferase activity at different ages in brain of Ts65Dn mice, an animal model for Down's syndrome and related neurodegenerative diseases.
    Contestabile A; Fila T; Bartesaghi R; Contestabile A; Ciani E
    J Neurochem; 2006 Apr; 97(2):515-26. PubMed ID: 16539660
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Primate models of cholinergic dysfunction.
    Liberini P; Cuello AC
    Funct Neurol; 1995; 10(1):45-54. PubMed ID: 7649501
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic Lithium Treatment in a Rat Model of Basal Forebrain Cholinergic Depletion: Effects on Memory Impairment and Neurodegeneration.
    Gelfo F; Cutuli D; Nobili A; De Bartolo P; D'Amelio M; Petrosini L; Caltagirone C
    J Alzheimers Dis; 2017; 56(4):1505-1518. PubMed ID: 28222508
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Choline acetyltransferase: the structure, distribution and pathologic changes in the central nervous system.
    Oda Y
    Pathol Int; 1999 Nov; 49(11):921-37. PubMed ID: 10594838
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pre- and post-synaptic cholinergic dysfunction in aged rodent brain regions: new findings and an interpretative review.
    Sherman KA; Friedman E
    Int J Dev Neurosci; 1990; 8(6):689-708. PubMed ID: 2288244
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distribution and co-localization of choline acetyltransferase and p75 neurotrophin receptors in the sheep basal forebrain: implications for the use of a specific cholinergic immunotoxin.
    Ferreira G; Meurisse M; Tillet Y; Lévy F
    Neuroscience; 2001; 104(2):419-39. PubMed ID: 11377845
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunolesion by 192IgG-saporin of rat basal forebrain cholinergic system: a useful tool to produce cortical cholinergic dysfunction.
    Schliebs R; Rossner S; Bigl V
    Prog Brain Res; 1996; 109():253-64. PubMed ID: 9009714
    [TBL] [Abstract][Full Text] [Related]  

  • 9. D1 dopamine receptor agonist-induced Fos-like immunoreactivity occurs in basal forebrain and mesopontine tegmentum cholinergic neurons and striatal neurons immunoreactive for neuropeptide Y.
    Robertson GS; Staines WA
    Neuroscience; 1994 Mar; 59(2):375-87. PubMed ID: 7911982
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The cholinergic system in aging and neuronal degeneration.
    Schliebs R; Arendt T
    Behav Brain Res; 2011 Aug; 221(2):555-63. PubMed ID: 21145918
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nucleus basalis (Ch4) and cortical cholinergic innervation in the human brain: observations based on the distribution of acetylcholinesterase and choline acetyltransferase.
    Mesulam MM; Geula C
    J Comp Neurol; 1988 Sep; 275(2):216-40. PubMed ID: 3220975
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Down's syndrome and Alzheimer's dementia: defining an association.
    Heston LL
    Psychiatr Dev; 1984; 2(4):287-94. PubMed ID: 6241313
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interactions between the amyloid and cholinergic mechanisms in Alzheimer's disease.
    Pákáski M; Kálmán J
    Neurochem Int; 2008 Nov; 53(5):103-11. PubMed ID: 18602955
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The cholinergic system in Alzheimer's disease.
    Kása P; Rakonczay Z; Gulya K
    Prog Neurobiol; 1997 Aug; 52(6):511-35. PubMed ID: 9316159
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The functional organization of the basal forebrain cholinergic system in primates and the role of this system in Alzheimer's disease.
    Price DL; Cork LC; Struble RG; Whitehouse PJ; Kitt CA; Walker LC
    Ann N Y Acad Sci; 1985; 444():287-95. PubMed ID: 3160283
    [No Abstract]   [Full Text] [Related]  

  • 16. Down's syndrome individuals begin life with normal levels of brain cholinergic markers.
    Kish S; Karlinsky H; Becker L; Gilbert J; Rebbetoy M; Chang LJ; DiStefano L; Hornykiewicz O
    J Neurochem; 1989 Apr; 52(4):1183-7. PubMed ID: 2522539
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Minocycline prevents cholinergic loss in a mouse model of Down's syndrome.
    Hunter CL; Bachman D; Granholm AC
    Ann Neurol; 2004 Nov; 56(5):675-88. PubMed ID: 15468085
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glycogen synthase kinase-3 reduces acetylcholine level in striatum via disturbing cellular distribution of choline acetyltransferase in cholinergic interneurons in rats.
    Zhao L; Chu CB; Li JF; Yang YT; Niu SQ; Qin W; Hao YG; Dong Q; Guan R; Hu WL; Wang Y
    Neuroscience; 2013; 255():203-11. PubMed ID: 24121130
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is the neuronal basis of Alzheimer's disease cholinergic or glutamatergic?
    Palmer AM; Gershon S
    FASEB J; 1990 Jul; 4(10):2745-52. PubMed ID: 2165009
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cholinergic system and memory in the rat: effects of chronic ethanol, embryonic basal forebrain brain transplants and excitotoxic lesions of cholinergic basal forebrain projection system.
    Arendt T; Allen Y; Marchbanks RM; Schugens MM; Sinden J; Lantos PL; Gray JA
    Neuroscience; 1989; 33(3):435-62. PubMed ID: 2636702
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.